{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:04:15Z","timestamp":1774494255474,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1053\/j.semdp.2017.11.001","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T09:45:25Z","timestamp":1510307125000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["In situ neoplasia in lymph node pathology"],"prefix":"10.1053","volume":"35","author":[{"given":"Naoki","family":"Oishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2017.11.001_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Revised","first-page":"421","article-title":"Follicular lymphoma","author":"Jaffe","year":"2017"},{"key":"10.1053\/j.semdp.2017.11.001_bib3","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Revised","first-page":"421","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2017"},{"key":"10.1053\/j.semdp.2017.11.001_bib4","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib5","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000000628","article-title":"Incidental and isolated follicular lymphoma in situ and mantle cell lymphoma in situ lack clinical significance","volume":"40","author":"Bermudez","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2011.052621","article-title":"In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior","volume":"97","author":"Carvajal-Cuenca","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.11.001_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2559.2011.03897.x","article-title":"Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes","volume":"59","author":"Henopp","year":"2011","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.001_bib9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semdp.2017.11.001_bib10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3324\/haematol.2013.085506","article-title":"Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies","volume":"98","author":"Pillai","year":"2013","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.11.001_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2559.2010.03529.x","article-title":"Intrafollicular neoplasia\/in situ follicular lymphoma: review of a series of 13 cases","volume":"56","author":"Montes-Moreno","year":"2010","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.001_bib12","doi-asserted-by":"crossref","unstructured":"Fend F, Cabecadas J, Gaulard P. et al. Early lesions in lymphoid neoplasia: conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden. J Hematop.;5:169-199; 2012.","DOI":"10.1007\/s12308-012-0148-6"},{"key":"10.1053\/j.semdp.2017.11.001_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2013.085548","article-title":"Nature and importance of follicular lymphoma precursors","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.11.001_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/PAP.0000000000000030","article-title":"Follicular dendritic cell pattern in early lymphomas involving follicles","volume":"21","author":"Carbone","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.993","article-title":"In situ follicular lymphoma: pathologic characteristics and diagnostic features","volume":"30","author":"Carbone","year":"2012","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.semdp.2017.11.001_bib16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1053\/j.semdp.2017.11.001_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.semdp.2017.11.001_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1044-579X(03)00016-6","article-title":"Chromosomal translocation t(14;18) in healthy individuals","volume":"13","author":"Schuler","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2017.11.001_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02899261","article-title":"Amplified bcl-2\/JH rearrangements in reactive lymphadenopathy","volume":"63","author":"Ohshima","year":"1993","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib20","doi-asserted-by":"crossref","first-page":"e6172","DOI":"10.1590\/1414-431x20176172","article-title":"Presence of t(14;18) translocation in healthy individuals varies according to ethnic background in the Brazilian population","volume":"50","author":"Levy","year":"2017","journal-title":"Braz J Med Biol Res"},{"key":"10.1053\/j.semdp.2017.11.001_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood.V98.2.486","article-title":"Low frequency of BCL-2\/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals","volume":"98","author":"Yasukawa","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1200\/JCO.2013.52.8190","article-title":"t(14;18) translocation: a predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2017.11.001_bib23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/leu.2009.9","article-title":"In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2\/IGH fusion gene in blood and lymph node","volume":"23","author":"Cheung","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2017.11.001_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2013.307","article-title":"Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma","volume":"28","author":"Schmidt","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2017.11.001_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.11.001_bib26","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","article-title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","volume":"122","author":"Bodor","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ccell.2016.07.006","article-title":"EZH2 and BCL6 cooperate to assemble CBX8-BCOR complex to repress bivalent promoters, mediate germinal center formation and lymphomagenesis","volume":"30","author":"Beguelin","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2017.11.001_bib28","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2011-07-368944","article-title":"A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma","volume":"118","author":"Bonzheim","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib29","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.3324\/haematol.2014.115782","article-title":"Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites","volume":"100","author":"Mamessier","year":"2015","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.11.001_bib30","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1002\/ajh.22169","article-title":"In situ follicular lymphoma associated with overt B- or T-cell lymphomas in the same lymph node","volume":"86","author":"Carbone","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2017.11.001_bib31","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1182\/blood-2010-10-299628","article-title":"How I treat: diagnosing and managing \"in situ\" lymphoma","volume":"117","author":"Carbone","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib32","doi-asserted-by":"crossref","first-page":"e0151735","DOI":"10.1371\/journal.pone.0151735","article-title":"Isolated follicles enriched for centroblasts and lacking t(14;18)\/BCL2 in lymphoid tissue: diagnostic and clinical implications","volume":"11","author":"Nybakken","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.semdp.2017.11.001_bib33","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/modpathol.2012.117","article-title":"Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues","volume":"25","author":"Adam","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2004-02-0738","article-title":"Low prevalence of circulating t(11;14)(q13; q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR","volume":"104","author":"Hirt","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib35","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/leu.2009.31","article-title":"t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals","volume":"23","author":"Lecluse","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2017.11.001_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/107327481201900307","article-title":"Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches","volume":"19","author":"Shah","year":"2012","journal-title":"Cancer Control"},{"key":"10.1053\/j.semdp.2017.11.001_bib37","doi-asserted-by":"crossref","first-page":"E333","DOI":"10.1002\/hed.23206","article-title":"In situ mantle cell lymphoma in the nasopharynx","volume":"35","author":"Koletsa","year":"2013","journal-title":"Head Neck"},{"key":"10.1053\/j.semdp.2017.11.001_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2007.02906.x","article-title":"In-situ mantle cell lymphoma--a report of two cases","volume":"52","author":"Aqel","year":"2008","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.001_bib39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3324\/haematol.2014.107938","article-title":"Early lymphoid lesions: conceptual, diagnostic and clinical challenges","volume":"99","author":"Ganapathi","year":"2014","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.11.001_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00125480-199811000-00011","article-title":"Mantle cell lymphoma","volume":"5","author":"Kurtin","year":"1998","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2559.2005.02323.x","article-title":"Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features","volume":"48","author":"Parrens","year":"2006","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2017.11.001_bib42","first-page":"1042","article-title":"Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature","volume":"7","author":"Hsu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib43","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.11.001_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-017-0598-1","article-title":"Role of SOX11 and genetic events cooperating with cyclin D1 in mantle cell lymphoma","volume":"19","author":"Bea","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1053\/j.semdp.2017.11.001_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.2009.140","article-title":"Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms","volume":"23","author":"Chen","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib46","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2017.11.001_bib47","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2017.11.001_bib48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/ajcp\/108.3.302","article-title":"Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow","volume":"108","author":"Vasef","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib49","first-page":"927","article-title":"Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections","volume":"10","author":"Vasef","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib50","first-page":"2253","article-title":"Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma","volume":"95","author":"Yatabe","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib51","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.leukres.2008.01.015","article-title":"Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib","volume":"32","author":"Breccia","year":"2008","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2017.11.001_bib52","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0002-9440(10)65022-5","article-title":"Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14)","volume":"156","author":"Pruneri","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1309\/AJCP5GE1PSBMBZTW","article-title":"An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia","volume":"136","author":"Sherman","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib54","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/modpathol.3880239","article-title":"Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia","volume":"13","author":"Miranda","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib55","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/modpathol.2016.136","article-title":"Cyclin D1 expression in peripheral T-cell lymphomas","volume":"29","author":"Song","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib56","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib57","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.11.001_bib58","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/leu.2008.213","article-title":"Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2","volume":"22","author":"Klier","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2017.11.001_bib59","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"key":"10.1053\/j.semdp.2017.11.001_bib60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.semcancer.2011.09.007","article-title":"The complex landscape of genetic alterations in mantle cell lymphoma","volume":"21","author":"Royo","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2017.11.001_bib61","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2017.11.001_bib62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/AJCP06VIKFMTRCXD","article-title":"Multifocal mantle cell lymphoma in situ in the setting of a composite lymphoma","volume":"143","author":"Sloan","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib63","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1309\/AJCP5RT4MRSDGKSX","article-title":"Coexisting follicular and mantle cell lymphoma with each having an in situ component: a novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma","volume":"133","author":"Roullet","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.11.001_bib64","first-page":"145129","article-title":"A rare presentation of in situ mantle cell lymphoma and follicular lymphoma: a case report and review of the literature","volume":"2014","author":"Taverna","year":"2014","journal-title":"Case Rep Hematol"},{"key":"10.1053\/j.semdp.2017.11.001_bib65","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.humpath.2013.07.007","article-title":"Clonally related composite follicular lymphoma and mantle cell lymphoma with clinicopathologic features and biological implications","volume":"44","author":"Wang","year":"2013","journal-title":"Hum Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017301235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017301235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T23:52:55Z","timestamp":1570319575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257017301235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0740257017301235"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2017.11.001","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ neoplasia in lymph node pathology","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}